At
Lonza, we combine technological innovation with world class manufacturing and
process excellence. Together, these enable our customers to deliver their
discoveries in the healthcare, preservation, and protection sectors.
We
are a preferred global partner to the pharmaceutical, biotech and specialty
ingredients markets. We work to prevent illness and promote a healthier world
by enabling our customers to deliver innovative medicines that help treat or
even cure a wide range of diseases. We also offer a broad range of microbial
control solutions, which help to create and maintain a healthy environment.
Founded
in 1897 in the Swiss Alps, Lonza today operates in 120 sites and offices in
more than 35 countries. With approximately 15,500 full-time employees, we are
built from high-performing teams and of individual employees who make a
meaningful difference to our own business, as well as the communities in which
we operate. The company generated sales of CHF 5.9 billion in 2019 with a CORE
EBITDA of CHF 1.6 billion. Find out more at www.lonza.com and follow us on Twitter
@LonzaGroup or Facebook @LonzaGroupAG.
At
Lonza, we combine technological innovation with world class manufacturing and
process excellence. Together, these enable our customers to deliver their
discoveries in the healthcare, preservation, and protection sectors.
We
are a preferred global partner to the pharmaceutical, biotech and specialty
ingredients markets. We work to prevent illness and promote a healthier world
by enabling our customers to deliver innovative medicines that help treat or
even cure a wide range of diseases. We also offer a broad range of microbial
control solutions, which help to create and maintain a healthy environment.
Founded
in 1897 in the Swiss Alps, Lonza today operates in 120 sites and offices in
more than 35 countries. With approximately 15,500 full-time employees, we are
built from high-performing teams and of individual employees who make a
meaningful difference to our own business, as well as the communities in which
we operate. The company generated sales of CHF 5.9 billion in 2019 with a CORE
EBITDA of CHF 1.6 billion. Find out more at www.lonza.com and follow us on Twitter
@LonzaGroup or Facebook @LonzaGroupAG.
工商備案信息
公司全稱:龍沙(中國)投資有限公司
法人代表:GORDON EDWARD BATES成立日期:2003-09-23注冊資本:8400萬美元